侯旭奔
-
副教授
博士生导师
硕士生导师
- 性别：男
- 出生日期：1990-03-22
- 毕业院校：山东大学
- 学历：研究生(博士后)
- 学位：医学博士学位
- 在职信息：在职
- 所在单位：药学院
- 入职时间： 2018-12-18
- 所属院系：
齐鲁医学院
,
药学院
,
药学院
,
药学院
,
药学院
,
药学院
- 学科：药物化学
- 办公地点：趵突泉校区景蓝斋
大学科技园3号楼1514室
- 电子邮箱：2f9b8c7347c192ec5d76755f95cac8ba0b25750945021a6c11dd0f08c8d6387e7c89138dbe5939fee4c921cf2742b1b1bedae8c8dd642f48fd7ce203d494bad6ac45213443cfefa96f15c5f214f46882d81503874fccdb3326b8bbdfdb066c2c4b3a11091f93ebde4959fc4bea3b746696981ce248886c9cd198401762f99ca3
访问量：
-
[1]
.
Bacterial Biosynthesis of Nitrile-Containing Natural Products: Basis for Recognition of Diversified Substrates.
ACS Catal.,
14,
17780-17793,
2024.
-
[2]
Chang, Yingjie.
Simultaneous inhibition of FLT3 and HDAC by novel 6-ethylpyrazine-2-Carboxamide derivatives provides therapeutic advantages in acute myelocytic leukemia.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,
279,
2024.
-
[3]
.
Development of a First-in-Class DNMT1/HDAC Inhibitor with Improved Therapeutic Potential and Potentiated Antitumor Immunity.
Journal of Medicianal Chemistry,
67,
16480,
2024.
-
[4]
.
Design and synthesis of novel benzoic acid derivatives as striatal-enriched protein tyrosine phosphatase (STEP) inhibitors with neuroprotective properties.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,
2024.
-
[5]
Liang, Tao.
Design, synthesis and biological evaluation of 3, 4-disubstituted-imidazolidine-2, 5-dione derivatives as HDAC6 selective inhibitors..
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,
221,
113526,
2021.
-
[6]
Liang, Tao.
Targeting histone deacetylases for cancer therapy: Trends and challenges.
ACTA PHARMACEUTICA SINICA B,
2023.
-
[7]
Zhao, Yunpeng.
Design, synthesis and bioactivity evaluations of 8-substituted-quinoli- ne-2-carboxamide derivatives as novel histone deacetylase (HDAC) inhibitors.
Bioorganic & medicinal chemistry,
85,
2023.
-
[8]
.
Deciphering the Allosteric Activation Mechanism of SIRT6 Using Molecular Dynamics Simulations.
Journal of Chemical Information and Modeling,
63,
5896,
2023.
-
[9]
Liang, Tao.
Potential applications of BPFP1 in Bcl-2 protein quantification, carcinoma cell visualization, cell sorting and early cancer diagnosis.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,
224,
113725,
2021.
-
[10]
.
Discovery of benzofuran-2-carboxylic acid derivatives as lymphoid tyrosine phosphatase (LYP) inhibitors for cancer immunotherapy.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,
258,
2023.
-
[11]
Liu, Meng.
Strategies to overcome drug resistance using SHP2 inhibitors..
ACTA PHARMACEUTICA SINICA B,
11,
3908-3924,
2021.
-
[12]
.
Fast Identification of Novel Lymphoid Tyrosine Phosphatase Inhibitors Using Target-Ligand Interaction-Based Virtual Screening.
Journal of Medicianal Chemistry,
57,
9309-9322,
2014.
-
[13]
Wen Li.
Recent advances in small molecule PROTACs for the treatment of cancer..
Curr Med Chem,
28,
4893-4909,
2020.
-
[14]
Liu, Meng.
Discovery of a Novel Benzimidazole Derivative Targeting Histone Deacetylase to Induce Ferroptosis and Trigger Immunogenic Cell Death.
Journal of Medicianal Chemistry,
2024.
-
[15]
邱雪婷.
An in-line method for high-throughput screening of protein tyrosine phosphatase receptor type O inhibitors by capillary electrophoresis based on electrophoretically mediated microanalysis.
Journal of chromatography A,
1713,
2024.
-
[16]
.
Interaction of PKR with STCS1: an indispensable step in the biosynthesis of lunularic acid in <i>Marchantia polymorpha</i>.
New Phytologist,
237,
515,
2023.
-
[17]
.
Discovery of benzofuran-2-carboxylic acid derivatives as lymphoid tyrosine phosphatase (LYP) inhibitors for cancer immunotherapy.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,
2023.
-
[18]
.
沙门氏菌III型分泌系统抗感染类抑制剂的筛选.
微生物学通报,
50,
1-20,
2023.
-
[19]
.
Characterization of an allosteric inhibitor of fungal-specific C-24 sterol methyltransferase to treat Candida albicans infections.
CELL CHEMICAL BIOLOGY,
30,
553-568.e7,
2023.
-
[20]
聂义明.
Development of QSRR model for hydroxamic acids using PCA-GA-BP algorithm incorporated with molecular interaction-based features.
FRONTIERS IN CHEMISTRY,
2022.